Literature DB >> 15787349

Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism.

C G Musso, R Guelman, F Varela, R Pidoux, C Schreck, G RosaDiez, L Plantalech, L Algranati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15787349     DOI: 10.1007/s11255-004-2077-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  1 in total

1.  Elimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study.

Authors:  Raoul Bergner; Katja Dill; Dietmar Boerner; Michael Uppenkamp
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.